RW
Highly rated in
17
conditions

Dr. Russell E. Ware

Burnet Campus
Cincinnati, OH
Highly rated in
17
conditions
Specialties:Pediatric Hematology Oncology | Pediatrics
Experience:32 Years
Clinical Trials:Currently Recruiting for 2 Trials
Accepts:New Patients
Highly rated in
17
conditions
About|Expertise|Insurance|Location|Research
Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

Check Dr. Russell E. Ware's experience treating your condition:
About Dr. Russell E. Ware

Russell Ware is a Pediatric Hematologist Oncology specialist and a Pediatrics expert in Cincinnati, Ohio. Ware has been practicing medicine for over 32 years and is highly rated in 17 conditions, according to our data. His top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, Hemolytic Anemia, and Bone Marrow Transplant. He is licensed to treat patients in Ohio. Ware is currently accepting new patients.

His clinical research consists of co-authoring 187 peer reviewed articles and participating in 12 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Russell E. Ware it is best to call his office and ask if your insurance is accepted.

Dr. Russell E. Ware accepts the following insurance:

  •  Ambetter
  •  CareSource
Call to see if your plan is accepted.
Locations
3333 Burnet Ave, Cincinnati, OH 45229
Background & Education
Graduate Institution
Duke University School Of Medicine, 1991
Specialties
Pediatric Hematology Oncology
Pediatrics
Licenses
Pediatric Hematology-Oncology in OH
Hospital Affiliations
Cincinnati Childrens Burnet Campus
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

12 Clinical Trials
EXpanding Treatment for Existing Neurological Disease (EXTEND)
Enrollment Status: Recruiting
Publish Date: April 07, 2022
Intervention Type: Drug
Study Drug: Hydroxyurea
Study Phase: Phase 2
Hydroxyurea Exposure Limiting Pregnancy and Follow-Up Lactation
Enrollment Status: Recruiting
Publish Date: December 10, 2021
Intervention Type: Other
Stroke Avoidance for Children in REpublica Dominicana (SACRED): A Prospective Research Study to Reduce Stroke in Children With Sickle Cell Anemia
Enrollment Status: Active, not recruiting
Publish Date: August 29, 2022
Intervention Type: Procedure, Drug
Study Phase: Not Applicable
Antibody Detection of Vaccine-Induced Secretory Effects
Enrollment Status: Active, not recruiting
Publish Date: July 20, 2022
Intervention Type: Behavioral
Repeated Employee Testing for Understanding Our Recovery to Normal
Enrollment Status: Active, not recruiting
Publish Date: July 20, 2022
Intervention Type: Diagnostic Test
Serology to Covid for Recording Exposures and Evaluating Needs (SCREEN)
Enrollment Status: Terminated
Publish Date: December 22, 2021
Intervention Type: Diagnostic Test
Realizing Effectiveness Across Continents With Hydroxyurea (REACH): A Phase I/II Pilot Study Of Hydroxyurea For Children With Sickle Cell Anemia
Enrollment Status: Active, not recruiting
Publish Date: December 15, 2021
Intervention Type: Drug
Study Drug: Hydroxyurea
Study Phase: Phase 1/Phase 2
TCD With Transfusions Changing to Hydroxyurea (TWiTCH): A Phase III Randomized Trial to Compare Standard Therapy (Erythrocyte Transfusions) With Alternative Therapy (Hydroxyurea) for the Maintenance of Lowered TCD Velocities in Pediatric Subjects With Sickle Cell Anemia and Abnormal Pre-treatment TCD Velocities
Enrollment Status: Terminated
Publish Date: July 22, 2020
Intervention Type: Drug
Study Phase: Phase 3
Optimizing Hydroxyurea Therapy in Children With Sickle Cell Anemia In Malaria Endemic Areas: The NOHARM Maximum Tolerated Dose (MTD) Study
Enrollment Status: Completed
Publish Date: February 20, 2020
Intervention Type: Drug
Study Phase: Phase 3
Hydoxyurea Exposure in Lactation: A Pharmacokinetics Study (HELPS)
Enrollment Status: Completed
Publish Date: August 26, 2019
Sparing Conversion to Abnormal TCD Elevation (SCATE) - a Phase III Clinical Trial to Compare Standard Care (Observation) With Alternative Therapy (Hydroxyurea) for Reducing the Risk of Converting to an Abnormal TCD Velocity in Children With Sickle Cell Anemia and Conditional Pre-treatment TCD Velocities.
Enrollment Status: Terminated
Publish Date: February 08, 2016
Intervention Type: Drug
Study Phase: Phase 3
Stroke With Transfusions Changing to Hydroxyurea
Enrollment Status: Terminated
Publish Date: January 18, 2013
Intervention Type: Procedure, Drug
Study Phase: Phase 3
View 10 Less Clinical Trials -
188 Total Publications
Blood diseases in Africa: Redressing unjust disparities is an urgent unmet need.
Journal: American journal of hematology
Published: September 30, 2022
Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
RM
Dr. Rebecca A. Marsh
Pediatric Hematology Oncology | Pediatrics
Highly rated in
15
conditions
Pediatric Hematology Oncology
Pediatrics

Cincinnati Childrens Hospital Medical Center

Burnet Campus

3333 Burnet Ave, 
Cincinnati, OH 

Rebecca Marsh is a Pediatric Hematologist Oncology specialist and a Pediatrics expert in Cincinnati, Ohio. Marsh has been practicing medicine for over 20 years and is highly rated in 15 conditions, according to our data. Her top areas of expertise are Hemophagocytic Lymphohistiocytosis, Non-Langerhans-Cell Histiocytosis, X-Linked Lymphoproliferative Disease, Histiocytosis, and Bone Marrow Transplant. She is licensed to treat patients in Ohio. Marsh is currently accepting new patients.

KM
Dr. Kasiani C. Myers
Pediatric Hematology Oncology | Hematology | Oncology
Highly rated in
27
conditions
Pediatric Hematology Oncology
Hematology
Oncology

Cincinnati Childrens Hospital Medical Center

Burnet Campus

3333 Burnet Ave, 
Cincinnati, OH 

Kasiani Myers is a Pediatric Hematologist Oncology specialist and a Hematologist in Cincinnati, Ohio. Myers has been practicing medicine for over 19 years and is highly rated in 27 conditions, according to our data. Her top areas of expertise are Shwachman-Diamond Syndrome, Congenital Aplastic Anemia, Fanconi Anemia, Aplastic Anemia, and Bone Marrow Transplant. She is licensed to treat patients in Ohio. Myers is currently accepting new patients.

MF
Dr. Maryam Fouladi
Pediatric Hematology Oncology | Hematology | Oncology
Highly rated in
23
conditions
Pediatric Hematology Oncology
Hematology
Oncology

Nationwide Childrens

Burnet Campus

3333 Burnet Ave, 
Cincinnati, OH 

Maryam Fouladi is a Pediatric Hematologist Oncology specialist and a Hematologist in Cincinnati, Ohio. Fouladi has been practicing medicine for over 32 years and is highly rated in 23 conditions, according to our data. Her top areas of expertise are Diffuse Midline Glioma H3 K27M-Mutant, Brain Tumor, Glioma, Medulloblastoma, and Bone Marrow Transplant. She is licensed to treat patients in Ohio. Fouladi is currently accepting new patients.